Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Dosage Forms and Strengths VYVANSE (lisdexamfetamine dimesylate) capsules: Capsules 10 mg: pink body/pink cap (imprinted with S489 and 10 mg) Capsules 20 mg: ivory body/ivory cap (imprinted with S489 and 20 mg) Capsules 30 mg: white body/orange cap (imprinted with S489 and 30 mg) Capsules 40 mg: white body/blue green cap (imprinted with S489 and 40 mg) Capsules 50 mg: white body/blue cap (imprinted with S489 and 50 mg) Capsules 60 mg: aqua blue body/aqua blue cap (imprinted with S489 and 60 mg) Capsules 70 mg: blue body/orange cap (imprinted with S489 and 70 mg) VYVANSE (lisdexamfetamine dimesylate) chewable tablets: Chewable tablets 10 mg: White to off-white round shaped tablet debossed with '10' on one side and 'S489' on the other Chewable tablets 20 mg: White to off-white hexagonal shaped tablet debossed with '20' on one side and 'S489' on the other Chewable tablets 30 mg: White to off-white arc triangular shaped tablet debossed with '30' on one side and 'S489' on the other Chewable tablets 40 mg: White to off-white capsule shaped tablet debossed with '40' on one side and 'S489' on the other Chewable tablets 50 mg: White to off-white arc square shaped tablet debossed with '50' on one side and 'S489' on the other Chewable tablets 60 mg: White to off-white arc diamond shaped tablet debossed with '60' on one side and 'S489' on the other 4
The encephalopathy was reversed by pantothenic acid supplementation, suggesting that it was due to homopantothenate-induced pantothenic acid deficiency (15)
10.1016/j.medj.2021.03.018 7 BaccouchR.ShiY.VernayE.Matheli-GuinletM.Taib-MaamarN.VilletteS.et al (2023)
Some transition to maintenance dosing indefinitely
Regional Segment Analysis of the Global IV Glutathione Treatment Market North America (U.S., Canada, Mexico) Europe (Germany, France, U.K., Italy, Spain, Rest of Europe) Asia-Pacific (China, Japan, India, Rest of APAC) South America (Brazil and the Rest of South America) The Middle East and Africa (UAE, South Africa, Rest of MEA) North America is anticipated to hold the largest share of the Global IV Glutathione Treatment Market over the predicted timeframe
US$ 26.50
US$ 24.79
US$ 21.13
US$ 20.38
US$ 22.24
US$ 28.78
US$ 29.49
US$ 26.26
